The lymphocyte/monocyte ratio predicts the efficacy of isatuximab plus pomalidomide in multiple myeloma patients Yutaka ShimazuJunya KandaMasayuki Hino Research Open access 17 May 2024 Article: 135
The later-line efficacy and safety of immune checkpoint inhibitors plus anlotinib in EGFR-mutant patients with EGFR-TKI-resistant NSCLC: a single-center retrospective study Xiaoyan YinXinchao LiuXiangjiao Meng Research Open access 17 May 2024 Article: 134
Effect of radiochemotherapy on peripheral immune response in glioblastoma Léa HampeSusy DaumoineMarion Thibaudin Research Open access 16 May 2024 Article: 133
The optimal threshold of PD-L1 combined positive score to predict the benefit of PD-1 antibody plus chemotherapy for patients with HER2-negative gastric adenocarcinoma: a meta-analysis Ji-Bin LiMing-Yu LaiMiao-Zhen Qiu Research Open access 16 May 2024 Article: 132
GGT5: a potential immunotherapy response inhibitor in gastric cancer by modulating GSH metabolism and sustaining memory CD8+ T cell infiltration Wenjing ZhaoZiwei LiangJiannan Yao Research Open access 15 May 2024 Article: 131
circATAD2 mitigates CD8+ T cells antitumor immune surveillance in breast cancer via IGF2BP3/m6A/PD-L1 manner Zhiling ZhangWenjie HuoJie Li Research Open access 15 May 2024 Article: 130
Evaluation of the antitumor effect of neoantigen peptide vaccines derived from the translatome of lung cancer Fenbao LianHaitao YangBaosong Xie Research Open access 14 May 2024 Article: 129
Codonopsis pilosula-derived glycopeptide dCP1 promotes the polarization of tumor-associated macrophage from M2-like to M1 phenotype Hongxu LiuMaojin YaoJiaoyan Ren Research Open access 14 May 2024 Article: 128
Epigenetic silencing of LDHB promotes hepatocellular carcinoma by remodeling the tumor microenvironment Peng ZhangYi WanChengsheng Zhang Research Open access 13 May 2024 Article: 127
Safety of immune checkpoint inhibitors in patients aged over 80 years: a retrospective cohort study Tatsuki IkomaToshihiko MatsumotoTakayasu Kurata Research Open access 11 May 2024 Article: 126
The efficacy and safety of adding PD-1 blockade to induction chemotherapy and concurrent chemoradiotherapy (IC-CCRT) for locoregionally advanced nasopharyngeal carcinoma: an observational, propensity score-matched analysis Ya-Nan JinMeng-Yun QiangJi-Jin Yao Research Open access 11 May 2024 Article: 125
Camrelizumab plus famitinib in previously chemo-immunotherapy treated patients with advanced NSCLC: results from an open-label multicenter phase 2 basket study Shengxiang RenAnwen XiongCaicun Zhou Research Open access 10 May 2024 Article: 124
Single-cell sequencing of tumour infiltrating T cells efficiently identifies tumour-specific T cell receptors based on the T cell activation score Chaoting ZhangShance LiZheming Lu Brief Report Open access 10 May 2024 Article: 123
Dual roles of HK3 in regulating the network between tumor cells and tumor-associated macrophages in neuroblastoma Xin WuTao MiDawei He Research Open access 07 May 2024 Article: 122
Integrative analysis of single-cell and bulk RNA sequencing unveils a machine learning-based pan-cancer major histocompatibility complex-related signature for predicting immunotherapy efficacy Jia-Lin FengBo LiangJun Chen Research Open access 07 May 2024 Article: 121
Chemoradiotherapy versus surgery after neoadjuvant chemoimmunotherapy in patients with stage III NSCLC: a real-world multicenter retrospective study Song GuanJifeng SunLujun Zhao Research Open access 07 May 2024 Article: 120
Efficacy and safety of surufatinib plus toripalimab, a chemotherapy-free regimen, in patients with advanced gastric/gastroesophageal junction adenocarcinoma, esophageal squamous cell carcinoma, or biliary tract cancer Panpan ZhangZhendong ChenLin Shen Research Open access 07 May 2024 Article: 119
Long-term survival after anti-PD-1 discontinuation in advanced cutaneous squamous cell carcinoma (cSCC): a proof of concept of benefit of concomitant cemiplimab and radiotherapy Barbara Bailly-CailléRomain LevardJean-Matthieu L’Orphelin Brief Report Open access 07 May 2024 Article: 118
Overexpressing S100A9 ameliorates NK cell dysfunction in estrogen receptor-positive breast cancer Yansong LiuMingcui LiFei Ma Research Open access 07 May 2024 Article: 117
Clinical outcomes of adjuvant nivolumab in resected stage III melanoma: comparison of CheckMate 238 trial and real-world data Justin C. MoserShailender BhatiaJeffrey Weber Research Open access 07 May 2024 Article: 116
Extracellular matrix stiffness and tumor-associated macrophage polarization: new fields affecting immune exclusion Ke-Xun YuWei-Jie YuanYong-Xiang Li Review Open access 02 May 2024 Article: 115
Expression patterns of novel immunotherapy targets in intermediate- and high-grade lung neuroendocrine neoplasms Bence FerenczKlára TörökBalázs Döme Research Open access 02 May 2024 Article: 114
Neutrophil-activating secretome characterizes palbociclib-induced senescence of breast cancer cells Gabriele FavarettoMarianna Nicoletta RossiFabrizio Antonangeli Research Open access 02 May 2024 Article: 113
New genetic insights into immunotherapy outcomes in gastric cancer via single-cell RNA sequencing and random forest model Dajun YuJie YangChao Zhu Research Open access 02 May 2024 Article: 112
Clonal expansion of shared T cell receptors reveals the existence of immune commonality among different lesions of synchronous multiple primary lung cancer Yadong WangZhicheng HuangNaixin Liang Research Open access 26 April 2024 Article: 111
Interleukin 33 supports squamous cell carcinoma growth via a dual effect on tumour proliferation, migration and invasion, and T cell activation Graziela PerriVanessa Garcia Vilas BoasAna Paula Campanelli Research Open access 25 April 2024 Article: 110
Synergistic immunomodulatory effect of synbiotics pre- and postoperative resection of pancreatic ductal adenocarcinoma: a randomized controlled study Sara MaherHesham A. ElmeligyManal Kamel Research Open access 25 April 2024 Article: 109
A2AR-mediated CXCL5 upregulation on macrophages promotes NSCLC progression via NETosis Qingyang LeiShanshan ZhenYi Zhang Research Open access 20 April 2024 Article: 108
A phase I trial of autologous RAK cell immunotherapy in metastatic renal cell carcinoma Jing XuWen ZhangJie Ma Research Open access 20 April 2024 Article: 107
Global real-world experiences with pembrolizumab in advanced urothelial carcinoma after platinum-based chemotherapy: the ARON-2 study Francesco MassariMatteo SantoniJoaquim Bellmunt Research Open access 18 April 2024 Article: 106
Correction to: Dominant‑negative transforming growth factor‑β receptor‑armoured mesothelin‑targeted chimeric antigen receptor T cells slow tumour growth in a mouse model of ovarian cancer Ke LiJing XuYu Kang Correction Open access 18 April 2024 Article: 105
Associations of granulocyte colony-stimulating factor with toxicities and efficacy of chimeric antigen receptor T-cell therapy in relapsed or refractory B-cell acute lymphoblastic leukemia Sha MaYing WangKailin Xu Research Open access 17 April 2024 Article: 104
Intratumor injection of BCG Ag85A high-affinity peptides enhanced anti-tumor efficacy in PPD-positive melanoma Lanqun QinGuiying ZhangZhengyun Zou Research Open access 17 April 2024 Article: 103
TLR5 agonist in combination with anti-PD-1 treatment enhances anti-tumor effect through M1/M2 macrophage polarization shift and CD8+ T cell priming Junseok LeeKeon-Il ImSeok-Goo Cho Research Open access 17 April 2024 Article: 102
Expansion of tumor-infiltrating lymphocytes from head and neck squamous cell carcinoma to assess the potential of adoptive cell therapy Sangjoon ChoiMofazzal HossainHee Jin Lee Research Open access 17 April 2024 Article: 101
Comparative performance of scFv-based anti-BCMA CAR formats for improved T cell therapy in multiple myeloma Sophia StockLuisa FertigSebastian Kobold Research Open access 17 April 2024 Article: 100
T-cell subsets and cytokines are indicative of neoadjuvant chemoimmunotherapy responses in NSCLC Ling YiZiwei XuYi Han Research Open access 15 April 2024 Article: 99
Incorporating IL7 receptor alpha signaling in the endodomain of B7H3-targeting chimeric antigen receptor T cells mediates antitumor activity in glioblastoma Nithidol SakunrangsitNattarika KhuisangeamSupannikar Tawinwung Research Open access 15 April 2024 Article: 98
Integrating bulk and single-cell sequencing data to construct a Scissor+ dendritic cells prognostic model for predicting prognosis and immune responses in ESCC Maosheng ChengJianqi XiongShuang Chen Research Open access 15 April 2024 Article: 97
CD200 is overexpressed in the pancreatic tumor microenvironment and predictive of overall survival Jessica WedigShrina JasaniThomas A. Mace Research Open access 15 April 2024 Article: 96
Dual-loss of PBRM1 and RAD51 identifies hyper-sensitive subset patients to immunotherapy in clear cell renal cell carcinoma Ziyang XuWenbin JiangJiejie Xu Research Open access 12 April 2024 Article: 95
Bifidobacterium modulation of tumor immunotherapy and its mechanism Bo PeiShixuan PengFuxiang Zhou Review Open access 02 April 2024 Article: 94
The prognostic and potentially immunomodulatory role of cartilage oligomeric matrix protein in patients with gastric and esophageal adenocarcinoma Konstantinos S. PapadakosGilar Gorji-BahriAnna M. Blom Research Open access 02 April 2024 Article: 93
Activation of STING by the novel liposomal TLC388 enhances the therapeutic response to anti-PD-1 antibodies in combination with radiotherapy Jhen-Yu ChenPo-Yu LinKevin Chih-Yang Huang Research Open access 02 April 2024 Article: 92
circFTO from M2 macrophage-derived small extracellular vesicles (sEV) enhances NSCLC malignancy by regulation miR-148a-3pPDK4 axis Qingtao LiuPei XuFangbao Ding Research Open access 30 March 2024 Article: 91
IL7 in combination with radiotherapy stimulates a memory T-cell response to improve outcomes in HNSCC models Justin YuJacob GadwaSana D. Karam Research Open access 30 March 2024 Article: 90
Ezabenlimab (BI 754091), an anti-PD-1 antibody, in patients with advanced solid tumours Manish R. PatelMelissa JohnsonLillian L. Siu Research Open access 30 March 2024 Article: 89
Prenatal inflammation exposure accelerates lung cancer tumorigenesis in offspring mouse: possible links to IRE1α/XBP1-mediated M2-like polarization of TAMs and PD-L1 up-expression Jingbo MaJian TanKeqiang Liu Research Open access 30 March 2024 Article: 88
The radiomics nomogram predicts the prognosis of pancreatic cancer patients with hepatic metastasis after chemoimmunotherapy Wenxin LuGuangyu WuLiwei Wang Research Open access 30 March 2024 Article: 87
SFRP1 decreases WNT-Mediated M2 macrophage marker expression in breast tissue Kelly J. GregoryHolly MasonSallie S. Schneider Brief Report Open access 30 March 2024 Article: 86
